Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nanjing
Clinical trial register · China

Clinical Trials in Nanjing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 09 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Nanjing 72 Lianyungang 2 Yixing 2 Beijing 2 Nanjin 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University203 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School87 Nanjing First Hospital, Nanjing Medical University72 Nanjing Medical University30 The Second Hospital of Nanjing Medical University30 Clear sponsor filter
Site location
Nanjing72 Lianyungang2 Yixing2 Beijing2 Nanjin1
All 23 locations
Target enrolment
to

Trials with a site in Nanjing

72 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Nanjing First Hospital, Nanjing Medical University
Observational
80
Nanjing
2027-02-01
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
310
Nanjing
2026-12-30
Not yet open
PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF
NCT07349979Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease, Stable GDMT
DrugGDMT
Nanjing First Hospital, Nanjing Medical University
Not applicable
1,154
Nanjing
2026-12-30
Not yet open
Nanjing First Hospital, Nanjing Medical University
Observational
67
Nanjing
2026-11-01
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
64
Nanjing
2026-10-08
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
600
Nanjing
2026-09-05
Recruiting
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease
NCT07764094PCI, Drug-coated Balloon, Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University
Observational
500
Chuzhou, Tongling, Huai'an, Lianyungang, Nanjing, Xuzhou, Yixing
2026-09-01
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
130
Nanjing
2026-08-05
Recruiting
68Ga-labeled Cholecystokinin Receptor (CCK2R) Targeted Molecular Probes in Early Tumor Diagnosis
NCT07914764Medullary Thyroid Carcinoma, Small Cell Lung Cancer ( SCLC ), Gastric Adenocarcinoma
Nanjing First Hospital, Nanjing Medical University
Observational
20
Nanjing
2026-08-01
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
40
Nanjing
2026-08
Recruiting
Progression, Management, and Clinical Outcomes of Coronary Artery Aneurysms
NCT07764081Coronary Artery Disease, Aneurysms, Coronary Intervention
Nanjing First Hospital, Nanjing Medical University
Observational
1,000
Nanjing
2026-07-31
Recruiting
Nanjing First Hospital, Nanjing Medical University
Phase 3
612
Nanjing
2026-07-15
Not yet open
Vascular Aging and Acute Kidney Injury After Cardiac Surgery
NCT07727772Acute Kidney Injury Cardiac Surgery, Postoperative Complications, Vascular Aging
Nanjing First Hospital, Nanjing Medical University
Observational
472
Nanjing
2026-07-01
Not yet open
Nanjing First Hospital, Nanjing Medical University
Phase 3
106
Nanjing
2026-07
By invitation
Nanjing First Hospital, Nanjing Medical University
Not applicable
184
Nanjing, Suzhou
2026-06-01
Not yet open
Nanjing First Hospital, Nanjing Medical University
Observational
1,300
Nanjing
2026-06-01
Active, closed
AI-CCTA for Predicting Cardiovascular Events in CAD
NCT07832175Coronary Artery Disease, Atherosclerotic Cardiovascular Disease
Nanjing First Hospital, Nanjing Medical University
Observational
3,000
Nanjing
2026-06-01
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
94
Nanjing
2026-02-11
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
220
Nanjing
2026-01-01
Recruiting
Nanjing First Hospital, Nanjing Medical University
Observational
1,000
Nanjing
2026-01-01
Recruiting
Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR
NCT07297641PCI, In-stent Restenosis, Intravascular Imaging Device
Nanjing First Hospital, Nanjing Medical University
Observational
1,500
Nanjing
2026-01-01
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
220
Nanjing
2026-01-01
Recruiting
Nanjing First Hospital, Nanjing Medical University
Phase 4
3,826
Nanjing
2026-01-01
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
50
Nanjing
2025-09-12
Not yet open
Nanjing First Hospital, Nanjing Medical University
Observational
8
Nanjing
2025-09-01
Recruiting
Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions
NCT07093788PCI, Coronary Arterial Disease (CAD), Calcified Coronary Lesions
Nanjing First Hospital, Nanjing Medical University
Not applicable
78
Lianyungang, Nanjing, Yixing
2025-09-01
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
100
Nanjing
2025-07-24
Not yet open
Nanjing First Hospital, Nanjing Medical University
Phase 4
40
Nanjing
2025-07-20
Active, closed
Nanjing First Hospital, Nanjing Medical University
Not applicable
68
Nanjing
2025-07-12
Recruiting
Nanjing First Hospital, Nanjing Medical University
Observational
500
Nanjing
2025-06-01
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
120
Nanjing
2025-06-01
Recruiting
Nanjing First Hospital, Nanjing Medical University
Phase 4
80
Nanjing
2025-06-01
Not yet open
Nanjing First Hospital, Nanjing Medical University
Observational
839
Nanjing
2025-06
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
168
Nanjing
2025-05-25
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
364
Nanjing
2025-05-14
Active, closed
Nanjing First Hospital, Nanjing Medical University
Not applicable
152
Nanjing
2025-05-01
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
74
Nanjing
2025-04-21
Recruiting
Nanjing First Hospital, Nanjing Medical University
Phase 4
120
Nanjing
2025-04-17
Recruiting
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
NCT06937112Lung Cancers, Pancreatic Cancer, Neuroendocrine Tumors, Thyroid Cancer
Nanjing First Hospital, Nanjing Medical University
Observational
20
Nanjing
2025-04-10
Active, closed
Nanjing First Hospital, Nanjing Medical University
Observational
200
Nanjing
2025-03-10
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
236
Nanjing
2025-01-25
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
30
Nanjing
2025-01-08
Recruiting
Effect of Subanesthetic Dose of Esketamine on Sleep Quality
NCT06773143Insomnia, Breast Cancer Surgery, Esketamine
DrugEsketamine
Nanjing First Hospital, Nanjing Medical University
Not applicable
184
Nanjing
2024-12-30
Recruiting
Nanjing First Hospital, Nanjing Medical University
Observational
30
Nanjing
2024-12-25
Recruiting
Nanjing First Hospital, Nanjing Medical University
Phase 3
1,000
Nanjing
2024-11-07
Active, closed
Nanjing First Hospital, Nanjing Medical University
Observational
100
Nanjing
2024-11-01
Recruiting
Clinical Study of Perioperative Sleep Disorders in Cardiac Surgery
NCT06778811Sleep Wake Disorders, Esketamine and the Quality of Recovery, Dexmedetomidine
Nanjing First Hospital, Nanjing Medical University
Phase 4
180
Nanjing
2024-10-11
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
1,332
Nanjing
2024-07-17
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
15
Nanjing
2024-06-30
Recruiting
Characteristics of Papez Loop Neural Network in T2DM （Type 2 Diabetes Mellitus）
NCT06912321Type 2 Diabetes, Insulin Resistance, Cognitive Impairment
Nanjing First Hospital, Nanjing Medical University
Observational
400
Nanjing
2024-05-01
Recruiting
Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment
NCT06405217DTC - Differentiated Thyroid Cancer, Thyroid Stimulating; Hormone, C, Radiotherapy; Complications
DrugRecombinant Human Thyroid Stimulating Hormone
Nanjing First Hospital, Nanjing Medical University
Not applicable
30
Nanjing
2024-04-20
Recruiting
Nanjing First Hospital, Nanjing Medical University
Phase 4
40
Nanjing
2024-03-15
Active, closed
Nanjing First Hospital, Nanjing Medical University
Observational
500
Nanjing
2024-03-12
Recruiting
Efficacy of Bioceramic Materials for Bone Defects Repair
NCT06249906Bone Lesion, Cartilage Degeneration, Osteo Arthritis Knee, Bone Fracture
Nanjing First Hospital, Nanjing Medical University
Not applicable
10
Nanjing
2024-02-20
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
30
Nanjing
2024-02-10
Recruiting
IVUS-guided DES Implantation in Coronary Calcification
NCT05800002Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University
Not applicable
864
Nanjing
2023-04-07
Active, closed
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
NCT05457582Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention, Cardiovascular Events
DrugHigh-intensity statin
Nanjing First Hospital, Nanjing Medical University
Not applicable
1,212
Nanjing
2023-03-30
Recruiting
Nanjing First Hospital, Nanjing Medical University
Observational
150
Nanjing
2022-07-10
Recruiting
TAVR for Aortic Valve Disease
NCT05439863Aortic Valve Disease
Nanjing First Hospital, Nanjing Medical University
Observational
5,000
Nanjing
2022-07-01
Recruiting
Nanjing First Hospital, Nanjing Medical University
Observational
5,000
Nanjing
2022-05-24
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
180
Nanjing
2022-05-23
Recruiting
National Registry and Cohort Study of Pulmonary Vascular Disease
NCT05368467Pulmonary Arterial Hypertension
Nanjing First Hospital, Nanjing Medical University
Observational
1,000
Guangzhou, Nanjing, Tianjin, Beijing, Changsha, Chendu, Shenyang, Wuhan
2022-03-29
Recruiting
Nanjing First Hospital, Nanjing Medical University
Phase 4
150
Nanjing
2022-03-15
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
210
Nanjing
2021-05-21
Active, closed
Nanjing First Hospital, Nanjing Medical University
Not applicable
784
Nanjing
2020-09-08
Recruiting
Circulating Non-coding RNA in Acute Ischemic Stroke With Endovascular Treatment (EVTRNA)
NCT04230785Stroke, Acute, Stroke, Ischemic, Endovascular Treatment
Nanjing First Hospital, Nanjing Medical University
Observational
300
Nanjing
2020-03-15
Recruiting
Nanjing First Hospital, Nanjing Medical University
Observational
3,000
Nanjing
2020-02-25
Recruiting
Circulating Non-coding RNA in Acute Ischemic Stroke (AISRNA)
NCT04175691Acute Stroke, Ischemic Stroke
Nanjing First Hospital, Nanjing Medical University
Observational
500
Nanjing
2019-11-24
Active, closed
Nanjing First Hospital, Nanjing Medical University
Observational
2,600
Nanjing
2019-08-28
Active, closed
Nanjing First Hospital, Nanjing Medical University
Not applicable
3,710
Nanjing
2019-08-20
Active, closed
Nanjing First Hospital, Nanjing Medical University
Not applicable
556
Nanjing
2018-12-26
Recruiting
Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome
NCT05397392Heart Failure, Kidney Diseases, Kidney Injury, Heart Valve Diseases
Nanjing First Hospital, Nanjing Medical University
Observational
1,200
Nanjing
2016-01
Rows per page Showing 1–72 of 72
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/city/nanjing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 09 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 72 of those studies with a site in Nanjing that also match the filters currently applied.

How many clinical trials are recruiting in Nanjing?

44 of the 72 studies on this page are recruiting new participants as of the 09 Nov 2026, 03:17 UTC sync. A further 16 have not yet opened recruitment, 11 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nanjing), 72 studies
PhaseStudiesRecruitingShare
Not applicable341947.2%
Observational281738.9%
Phase 4769.7%
Phase 3324.2%

Most active sponsors

Lead sponsors with the most studies (Nanjing)
Lead sponsorStudiesRecruiting
Nanjing First Hospital, Nanjing Medical University7244
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.